Key facts
- It has raised $2.0M across 1 recorded rounds; the latest was Seed Round ($1.0M) in May 2024.
- Notable investors include SC Launch, InvestSC.
- Precision Genetics has filed 1 Form D with the SEC, most recently Jan 2025 ($1.0M sold to 1 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Precision Genetics
Funding rounds
1 roundsAbout Precision Genetics
Provider of lab services intended to improve and personalize medicine and treatment plans. The company's platform combines technology, genetic markers, molecular data, and clinical evidence into a comprehensive and actionable report to address their risks and treatment pathways based on their genetics, demographics, lifestyle, and medical conditions, enabling physicians and healthcare providers to develop individualized treatment and prevention plans for their patients, while empowering patients to utilize their molecular results.
- Sector
- Healthcare
- HQ
- Greenville, SC, United States
- Founded
- 2017
- Employees
- 37
- Website
- precisiongenetics.com/
- Ownership
- Privately Held (backing)
Precision Genetics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Precision Genetics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Precision Genetics in its N-PORT filings yet. We sweep new filings monthly.